Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENFORTUMAB VEDOTIN-EJFV Cause Metastases to bone? 30 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Metastases to bone have been filed in association with ENFORTUMAB VEDOTIN-EJFV. This represents 0.8% of all adverse event reports for ENFORTUMAB VEDOTIN-EJFV.

30
Reports of Metastases to bone with ENFORTUMAB VEDOTIN-EJFV
0.8%
of all ENFORTUMAB VEDOTIN-EJFV reports
2
Deaths
6
Hospitalizations

How Dangerous Is Metastases to bone From ENFORTUMAB VEDOTIN-EJFV?

Of the 30 reports, 2 (6.7%) resulted in death, 6 (20.0%) required hospitalization.

Is Metastases to bone Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENFORTUMAB VEDOTIN-EJFV. However, 30 reports have been filed with the FAERS database.

What Other Side Effects Does ENFORTUMAB VEDOTIN-EJFV Cause?

Rash (560) Malignant neoplasm progression (410) Neuropathy peripheral (410) Fatigue (281) Pruritus (260) Diarrhoea (257) Death (238) Decreased appetite (230) Off label use (193) Alopecia (185)

What Other Drugs Cause Metastases to bone?

LETROZOLE (1,735) RIBOCICLIB (1,538) FULVESTRANT (1,525) ZOLEDRONIC ACID (1,087) DENOSUMAB (1,053) TAMOXIFEN (894) LEUPROLIDE (848) EVEROLIMUS (845) PACLITAXEL (820) PALBOCICLIB (793)

Which ENFORTUMAB VEDOTIN-EJFV Alternatives Have Lower Metastases to bone Risk?

ENFORTUMAB VEDOTIN-EJFV vs ENFORTUMAB VEDOTIN\ENFORTUMAB VEDOTIN-EJFV ENFORTUMAB VEDOTIN-EJFV vs ENFUVIRTIDE ENFORTUMAB VEDOTIN-EJFV vs ENOXAPARIN ENFORTUMAB VEDOTIN-EJFV vs ENOXAPARIN - WINTHROP ENFORTUMAB VEDOTIN-EJFV vs ENSIFENTRINE

Related Pages

ENFORTUMAB VEDOTIN-EJFV Full Profile All Metastases to bone Reports All Drugs Causing Metastases to bone ENFORTUMAB VEDOTIN-EJFV Demographics